- $3.16m
- -$5.06m
Annual cashflow statement for GRI Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9.3 | -7.02 | -13 | -8.21 | -12 |
| Depreciation | |||||
| Non-Cash Items | 0.686 | 0.249 | 2.36 | 0.04 | 0.841 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.22 | -0.566 | 1.68 | -0.448 | 0.925 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -8.31 | -7.13 | -8.99 | -8.61 | -10.2 |
| Capital Expenditures | 0 | — | -0.008 | 0 | -0.003 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -3.84 | 3.78 | — | — | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -3.84 | 3.78 | -0.008 | 0 | -0.003 |
| Financing Cash Flow Items | — | — | 0.269 | -2.03 | -2.17 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 15.7 | 3.43 | 10.8 | 11.8 | 13.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.59 | 0.079 | 1.8 | 3.22 | 3.2 |